Project Proposals
(Last updated April 21, 2023)
Proposing a new project. INHANCE members who have contributed data to the INHANCE pooled dataset are welcome to propose additional analysis, by filling out the analysis proposal form. Proposals are reviewed by the executive committee and voted on for approval. After approval by the executive committee, the proposals are circulated to the relevant members for participation in the project. This table summarizes the status for all current proposals by study.
INHANCE Projects awaiting approval or data from study PIs
| Project leaders | Project | Type | Status |
| Boffetta/Saltz |
follow-up only
|
Feasible in 8 studies; PI plans to apply for grant funding (Aug. 2021) | |
| Curado |
case-control only
|
Approved for 14 studies; awaiting 9 PI responses (April 2023) |
|
| Boffetta |
follow-up only
|
Approved for 13 studies; awaiting 3 PI responses and the relevant data (April 2023) |
|
| Boffetta |
follow-up only
|
Approved for 13 studies; awaiting 3 PI responses and the relevant data (April 2023) |
DTA=data transfer agreement
INHANCE Projects approved and on-going
| Project leaders | Date | Project | Type | Status | Pooled data version |
| Boccia/La Vecchia | February 2013 | miRNA & other factors on recurrence and 2nd primary |
follow-up only
|
Manuscripts published and in preparation | 1.5 |
| Zevallos | January 2016 | GERD |
case-control only
|
Circulated | 1.5 |
| Boccia/Leoncini/Vukovic | July 2017 | BMI and survival |
follow-up only
|
Manuscript in preparation | |
| Schwartz | March 2020 | Risk factor for oral cavity cancer among never tobacco users |
case-control only
|
Manuscript in preparation (Mar. 2022) | 1.5 |
| Lee | August 2017 | Passive smoking |
case-control only
|
Analysis ongoing | 1.5 |
| Hashibe | August 2017 | Coffee/tea |
case-control only
|
Analysis ongoing | 1.5 |
| Olshan | November 2018 | SES interaction |
case-control only
|
Analysis ongoing | 1.5 |
| Wünsch Filho | November 2019 | Milk and dairy |
case-control only
|
Analysis ongoing | 1.5 |
| Luce | May 2015 | Salivary | case-control only | Analysis ongoing | 1.5 |
| Olshan | August 2019 | Oral health survival | follow-up only |
Analysis on-going (Oct. 18, 2021)
|
1.5 |
| Rozek | January 2019 | Prognostic calculator | follow-up only |
Analysis on-going (Oct. 20, 2021)
|
1.5 |
| La Vecchia | February 2013 | risk factors among the elderly | case-control only | Analysis on-going (Sept. 10, 2021) | 1.5 |
| Edefonti | May 2012 | Single nutrient | case-control only |
Analysis ongoing (Sept. 20, 2021)
|
1.5 |
| Mondul | July 2021 | Statin use | case-control + follow-up |
Analysis ongoing (Oct. 28, 2021)
|
1.5 |
| Zhang | January 2021 | Illicit drug use | case-control only |
Analysis ongoing (Mar. 2022)
|
1.5 |
| Boffetta |
January 2022
|
Aspirin |
case-control only
|
Analysis on-going
|
1.5 |
na = not applicable